Anne Li January 26th, 2018
Cedars-Sinai investigators have developed a new, more accurate set of guidelines for assessing the severity of head and neck cancers and predicting patient survival. The new guidelines, center around counting the number of malignant lymph nodes found in each patient. For decades, doctors have determined the stage and predicted the progression of head and neck cancers based primarily on nodal size, location and how far the cancer has spread beyond the lymph nodes, but they have given less importance to the number of cancerous nodes.
See original article at: https://www.sciencedaily.com/releases/2018/01/180124100601.htm